Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Oyster Point Pharma, Inc. (OYST)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-05-18Dec-31-17
   10-K10-K10-K10-K8-KS-1/A
Net income  -100.7-70.5-45.7-16.50.0-19.1
Depreciation and amortization  0.10.10.0   
Stock-based compensation  11.97.03.30.2 0.1
Change in working capital   [+]-2.45.1-6.8-0.7 0.8
Other operating activities  1.60.08.40.0 13.5
Cash from operations  -89.4-58.4-40.8-17.1 -4.7
   
Capital expenditures  -1.5-0.7-0.20.0 0.0
Cash from investing  -1.5-0.7-0.20.0 0.0
   
Issuance of common stock, net  95.0112.682.1   
Option exercises  1.60.30.0   
Financing costs  -4.9     
Other cash from financing  -6.70.292.9  26.2
Cash from financing  91.6112.5175.00.0 26.2
   
Free cash flow  -90.9-59.1-41.0-17.1 -4.7
        Per share (diluted)  ($3.49)($2.45)($8.95)($12.10) ($3.31)
   
Cash paid for interest  2.4     

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy